4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-042453
Chief Medical Officer sold 2,000 shares at an average $86.76 ($173,512)
- Chief Medical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Chief Medical Officer | 2018-07-10 | Option exercise | +2,000 | $35.16 | $70,320 | 2,924 | D |
| Bowden Christopher Chief Medical Officer | 2018-07-10 | Sale | −1,200 | $86.42 | $103,704 | 1,724 | D |
| Bowden Christopher Chief Medical Officer | 2018-07-10 | Sale | −800 | $87.26 | $69,808 | 924 | D |
| Derivatives | |||||||
| Bowden Christopher Chief Medical Officer | 2018-07-10 | Option exercise · Stock option (right to buy) | −2,000 | 93,000 | D | ||
| Open-market sales · 2,000 sh · avg $86.76 · $173,512 | |||||||
Loading xslF345X03/doc4.xml…